Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 26
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Nature ; 623(7989): 938-941, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37783227

RESUMEN

Large constellations of bright artificial satellites in low Earth orbit pose significant challenges to ground-based astronomy1. Current orbiting constellation satellites have brightnesses between apparent magnitudes 4 and 6, whereas in the near-infrared Ks band, they can reach magnitude 2 (ref. 2). Satellite operators, astronomers and other users of the night sky are working on brightness mitigation strategies3,4. Radio emissions induce further potential risk to ground-based radio telescopes that also need to be evaluated. Here we report the outcome of an international optical observation campaign of a prototype constellation satellite, AST SpaceMobile's BlueWalker 3. BlueWalker 3 features a 64.3 m2 phased-array antenna as well as a launch vehicle adaptor (LVA)5. The peak brightness of the satellite reached an apparent magnitude of 0.4. This made the new satellite one of the brightest objects in the night sky. Additionally, the LVA reached an apparent V-band magnitude of 5.5, four times brighter than the current International Astronomical Union recommendation of magnitude 7 (refs. 3,6); it jettisoned on 10 November 2022 (Universal Time), and its orbital ephemeris was not publicly released until 4 days later. The expected build-out of constellations with hundreds of thousands of new bright objects1 will make active satellite tracking and avoidance strategies a necessity for ground-based telescopes.

2.
Gen Comp Endocrinol ; 300: 113636, 2021 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-33017581

RESUMEN

Hyperactivity in the sympathetic nervous system has been shown to be related to the development of ovarian pathologies. In addition, obesity has been found to be associated with multiple reproductive anomalies and is considered a chronic stress condition of low intensity with changes in the peripheral sympathetic activity. Therefore, in the present study, we aimed to evaluate if the information reaching the ovaries through the superior ovarian nerve (SON) modifies the ovarian function of Zucker fatty rats. We performed a unilateral section of the SON at 32 days of age and autopsies were carried out on the day of the first vaginal estrus. The results showed that fatty animals do not ovulate on the day of the first vaginal estrus and exhibit an increase in catecholaminergic fibers and the presence of precystic structures in the ovaries, without changes in the onset of puberty or in the secretion of ovarian and hypophyseal hormones. We also found that the section of the right SON resulted in ovulation on the day of the first vaginal estrus, which was accompanied by a decrease in ovarian noradrenaline content. The section of the left SON caused a delay in puberty without changes in the rest of the parameters. These results provide functional evidence that the peripheral sympathetic innervation participates in the regulation of ovarian functions in an animal model of genetic obesity.


Asunto(s)
Tejido Nervioso/fisiología , Ovario/inervación , Ovulación/fisiología , Animales , Catecolaminas/metabolismo , Femenino , Ovario/anatomía & histología , Ratas Zucker , Maduración Sexual/fisiología
3.
Int J Mol Sci ; 20(12)2019 Jun 25.
Artículo en Inglés | MEDLINE | ID: mdl-31242676

RESUMEN

Upon inflammation, monocyte-derived macrophages (MΦ) infiltrate blood vessels to regulate several processes involved in vascular pathophysiology. However, little is known about the mediators involved. Macrophage polarization is crucial for a fast and efficient initial response (GM-MΦ) and a good resolution (M-MΦ) of the inflammatory process. The functional activity of polarized MΦ is exerted mainly through their secretome, which can target other cell types, including endothelial cells. Endoglin (CD105) is a cell surface receptor expressed by endothelial cells and MΦ that is markedly upregulated in inflammation and critically involved in angiogenesis. In addition, a soluble form of endoglin with anti-angiogenic activity has been described in inflammation-associated pathologies. The aim of this work was to identify components of the MΦ secretome involved in the shedding of soluble endoglin. We find that the GM-MΦ secretome contains metalloprotease 12 (MMP-12), a GM-MΦ specific marker that may account for the anti-angiogenic activity of the GM-MΦ secretome. Cell surface endoglin is present in both GM-MΦ and M-MΦ, but soluble endoglin is only detected in GM-MΦ culture supernatants. Moreover, MMP-12 is responsible for the shedding of soluble endoglin in vitro and in vivo by targeting membrane-bound endoglin in both MΦ and endothelial cells. These data demonstrate a direct correlation between GM-MΦ polarization, MMP-12, and soluble endoglin expression and function. By targeting endothelial cells, MMP-12 may represent a novel mediator involved in vascular homeostasis.


Asunto(s)
Endoglina/metabolismo , Células Endoteliales/metabolismo , Mediadores de Inflamación/metabolismo , Macrófagos/metabolismo , Metaloproteinasa 12 de la Matriz/metabolismo , Animales , Células Cultivadas , Modelos Animales de Enfermedad , Susceptibilidad a Enfermedades , Endoglina/genética , Expresión Génica , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Humanos , Inflamación/etiología , Inflamación/metabolismo , Factor Estimulante de Colonias de Macrófagos/metabolismo , Macrófagos/inmunología , Ratones , Modelos Biológicos
4.
Invest Clin ; 55(3): 227-37, 2014 Sep.
Artículo en Español | MEDLINE | ID: mdl-25272522

RESUMEN

Some infectious pathogens have the capacity to affect cancer progression. In the present paper we studied the effect of infection or immunization with Trypanosoma cruzi (Tc) against malignant melanoma development. We worked on 258 C57BL/6 male mice divided in five melanoma groups: control melanoma, melanoma Tc acutely infected, melanoma Tc chronically infected, melanoma Tc immunized and infected melanoma; and three control groups: healthy, Tc acutely infected and Tc chronically infected. 100.000 B16-BL6 melanoma cells were inoculated in the thigh of melanoma groups; 3 or 20 trypomastigotes/g were inoculated intraperitoneally in chronic or acute Tc groups, before the melanoma injection, respectively; melanoma Tc immunized were subcutaneously inoculated with 30.000 formaldehide-fixed epimastigotes diluted in complete Freund's adjuvant and the infected melanoma group was inoculated with melanoma cells obtained from melanoma Tc acutely infected mice. We evaluated survival, parasitemia, tumor volume and tumor histopathology. Results showed that in mice infected with Tc, the tumor development and survival were significantly lower as compared with control melanoma and melanoma Tc immunized. Histopathologically, the tumor displayed necrosis areas with melanin deposits, cytopathic degeneration and amastigotes in parasitophorous vacuoles. In conclusion, Tc inhibits the development of malignant melanoma, increasing C57BL/6 survival, a phenomena that could be related to the parasite tumoral invasive capacity, its ability to produce melanoma cell lysis and to induce a robust immune response.


Asunto(s)
Enfermedad de Chagas/inmunología , Melanoma/inmunología , Melanoma/mortalidad , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/mortalidad , Animales , Enfermedad de Chagas/complicaciones , Masculino , Melanoma/complicaciones , Ratones , Ratones Endogámicos C57BL , Neoplasias Cutáneas/complicaciones , Tasa de Supervivencia
5.
J Innate Immun ; 15(1): 517-530, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37040733

RESUMEN

Toll-like receptor 7 (TLR7) is an endosomal pathogen-associated molecular pattern (PAMP) receptor that senses single-stranded RNA (ssRNA) and whose engagement results in the production of type I IFN and pro-inflammatory cytokines upon viral exposure. Recent genetic studies have established that a dysfunctional TLR7-initiated signaling is directly linked to the development of inflammatory responses. We present evidence that TLR7 is preferentially expressed by monocyte-derived macrophages generated in the presence of M-CSF (M-MØ). We now show that TLR7 activation in M-MØ triggers a weak MAPK, NFκB, and STAT1 activation and results in low production of type I IFN. Of note, TLR7 engagement reprograms MAFB+ M-MØ towards a pro-inflammatory transcriptional profile characterized by the expression of neutrophil-attracting chemokines (CXCL1-3, CXCL5, CXCL8), whose expression is dependent on the transcription factors MAFB and AhR. Moreover, TLR7-activated M-MØ display enhanced pro-inflammatory responses and a stronger production of neutrophil-attracting chemokines upon secondary stimulation. As aberrant TLR7 signaling and enhanced pulmonary neutrophil/lymphocyte ratio associate with impaired resolution of virus-induced inflammatory responses, these results suggest that targeting macrophage TLR7 might be a therapeutic strategy for viral infections where monocyte-derived macrophages exhibit a pathogenic role.


Asunto(s)
Monocitos , Receptor Toll-Like 7 , Humanos , Receptor Toll-Like 7/metabolismo , Monocitos/metabolismo , Factor Estimulante de Colonias de Macrófagos/metabolismo , Infiltración Neutrófila , Citocinas/metabolismo , Macrófagos/metabolismo , Quimiocinas/metabolismo
6.
JCI Insight ; 8(24)2023 Dec 22.
Artículo en Inglés | MEDLINE | ID: mdl-37917179

RESUMEN

Monocyte-derived macrophages, the major source of pathogenic macrophages in COVID-19, are oppositely instructed by macrophage CSF (M-CSF) or granulocyte macrophage CSF (GM-CSF), which promote the generation of antiinflammatory/immunosuppressive MAFB+ (M-MØ) or proinflammatory macrophages (GM-MØ), respectively. The transcriptional profile of prevailing macrophage subsets in severe COVID-19 led us to hypothesize that MAFB shapes the transcriptome of pulmonary macrophages driving severe COVID-19 pathogenesis. We have now assessed the role of MAFB in the response of monocyte-derived macrophages to SARS-CoV-2 through genetic and pharmacological approaches, and we demonstrate that MAFB regulated the expression of the genes that define pulmonary pathogenic macrophages in severe COVID-19. Indeed, SARS-CoV-2 potentiated the expression of MAFB and MAFB-regulated genes in M-MØ and GM-MØ, where MAFB upregulated the expression of profibrotic and neutrophil-attracting factors. Thus, MAFB determines the transcriptome and functions of the monocyte-derived macrophage subsets that underlie pulmonary pathogenesis in severe COVID-19 and controls the expression of potentially useful biomarkers for COVID-19 severity.


Asunto(s)
COVID-19 , SARS-CoV-2 , Humanos , SARS-CoV-2/metabolismo , COVID-19/metabolismo , Macrófagos/metabolismo , Macrófagos Alveolares/metabolismo , Biomarcadores/metabolismo , Factor de Transcripción MafB/genética , Factor de Transcripción MafB/metabolismo
7.
Front Immunol ; 11: 603507, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33312178

RESUMEN

Defective IFN production and exacerbated inflammatory and pro-fibrotic responses are hallmarks of SARS-CoV-2 infection in severe COVID-19. Based on these hallmarks, and considering the pivotal role of macrophages in COVID-19 pathogenesis, we hypothesize that the transcription factors MAFB and MAF critically contribute to COVID-19 progression by shaping the response of macrophages to SARS-CoV-2. Our proposal stems from the recent identification of pathogenic lung macrophage subsets in severe COVID-19, and takes into consideration the previously reported ability of MAFB to dampen IFN type I production, as well as the critical role of MAFB and MAF in the acquisition and maintenance of the transcriptional signature of M-CSF-conditioned human macrophages. Solid evidences are presented that link overexpression of MAFB and silencing of MAF expression with clinical and biological features of severe COVID-19. As a whole, we propose that a high MAFB/MAF expression ratio in lung macrophages could serve as an accurate diagnostic tool for COVID-19 progression. Indeed, reversing the macrophage MAFB/MAF expression ratio might impair the exacerbated inflammatory and profibrotic responses, and restore the defective IFN type I production, thus becoming a potential strategy to limit severity of COVID-19.


Asunto(s)
COVID-19/inmunología , Macrófagos/inmunología , Factores de Transcripción Maf/inmunología , Factor de Transcripción MafB/inmunología , SARS-CoV-2/inmunología , COVID-19/genética , COVID-19/virología , Perfilación de la Expresión Génica/métodos , Regulación de la Expresión Génica/genética , Regulación de la Expresión Génica/inmunología , Interacciones Huésped-Patógeno/genética , Interacciones Huésped-Patógeno/inmunología , Humanos , Macrófagos/metabolismo , Factores de Transcripción Maf/genética , Factores de Transcripción Maf/metabolismo , Factor de Transcripción MafB/genética , Factor de Transcripción MafB/metabolismo , SARS-CoV-2/fisiología , Índice de Severidad de la Enfermedad
8.
Infect Immun ; 76(5): 2149-56, 2008 May.
Artículo en Inglés | MEDLINE | ID: mdl-18299340

RESUMEN

The P8 proteoglycolipid complex (P8 PGLC) is a glyconjugate expressed by Leishmania mexicana complex parasites. We previously have shown that vaccination with P8 PGLC provides protection against cutaneous leishmaniasis in susceptible BALB/c mice. However, the biological importance of this complex remains unknown. Here we show that P8 PGLC localizes to the surface of Leishmania pifanoi amastigotes and that upon exposure to macrophages, P8 PGLC binds and induces inflammatory cytokine and chemokine mRNAs such as tumor necrosis factor alpha and RANTES early after stimulation. Our studies indicate that cytokine and chemokine induction is dependent upon Toll-like receptor 4 (TLR4). Interestingly, key inflammatory cytokines and chemokines (such as interleukin-6 [IL-6], macrophage inflammatory protein 1beta, and beta interferon [IFN-beta]) that can be induced through TLR4 activation were not induced or only slightly upregulated by P8 PGLC. Activation by P8 PGLC does not occur in the presence of TLR4 alone and requires both CD14 and myeloid differentiation protein 2 for signaling; this requirement may be responsible for the limited TLR4 response. This is the first characterization of a TLR4 ligand for Leishmania. In vitro experiments indicate that L. pifanoi amastigotes induce lower levels of cytokines in macrophages in the absence of TLR4; however, notably higher IL-10/IFN-gamma ratios were found for TLR4-deficient mice than for BALB/c mice. Further, increased levels of parasites persist in BALB/c mice deficient in TLR4. Taken together, these results suggest that TLR4 recognition of Leishmania pifanoi amastigotes is important for the control of infection and that this is mediated, in part, through the P8 PGLC.


Asunto(s)
Citocinas/biosíntesis , Leishmania/inmunología , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/parasitología , Proteolípidos/inmunología , Receptor Toll-Like 4/metabolismo , Proteínas Adaptadoras Transductoras de Señales/inmunología , Animales , Recuento de Células , Línea Celular , Células Cultivadas , Citocinas/genética , Femenino , Perfilación de la Expresión Génica , Humanos , Leishmania/química , Leishmaniasis/inmunología , Leishmaniasis/parasitología , Receptores de Lipopolisacáridos/inmunología , Antígeno 96 de los Linfocitos , Proteínas de la Membrana/análisis , Proteínas de la Membrana/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Proteolípidos/análisis , Proteolípidos/aislamiento & purificación , Receptor Toll-Like 4/deficiencia
9.
Immunobiology ; 210(2-4): 185-93, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16164025

RESUMEN

Leishmaniasis is a parasitic disease that courses with cutaneous or visceral clinical manifestations. The amastigote stage of the parasite infects phagocytes and modulates the effector function of the host cells. Our group has described that the interaction between Leishmania and immature monocyte-derived dendritic cells (DCs) takes place through dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), a C-type lectin that specifically recognizes fungal, viral and bacterial pathogens. The DC-SIGN-mediated recognition of Leishmania amastigotes does not induce DC maturation, and the DC-SIGN ligand/s on Leishmania parasites is/are still unknown. We have also found that the DC-SIGN-related molecule L-SIGN, specifically expressed in lymph node and liver sinusoidal endothelial cells, acts as a receptor for L. infantum, the parasite responsible for visceral leishmaniasis, but does not recognize L. pifanoi, which causes the cutaneous form of the disease. Therefore, DC-SIGN and L-SIGN differ in their ability to interact with Leishmania species responsible for either visceral or cutaneous leishmaniasis. A deeper knowledge of the parasite-C-type lectin interaction may be helpful for the design of new DC-based therapeutic vaccines against Leishmania infections.


Asunto(s)
Moléculas de Adhesión Celular/inmunología , Lectinas Tipo C/inmunología , Leishmania/inmunología , Leishmaniasis/inmunología , Fagocitos/parasitología , Receptores de Superficie Celular/inmunología , Animales , Moléculas de Adhesión Celular/metabolismo , Humanos , Lectinas Tipo C/metabolismo , Leishmania/metabolismo , Leishmaniasis/metabolismo , Receptores de Superficie Celular/metabolismo
10.
Trans R Soc Trop Med Hyg ; 96 Suppl 1: S3-7, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12055848

RESUMEN

One of the features of the genus Leishmania is the diversity of tropism/disease resulting from infection. With notable exceptions, the form (visceral, cutaneous, diffuse cutaneous, mucocutaneous) and severity of disease is a function of the infecting Leishmania species together with host genetics and consequent inflammatory and immune responses. It has become evident from genetic and immunological studies using the murine model that the various members of the genus Leishmania differ in aspects of their 'approach' to the host immune system. We are just beginning to appreciate the complexities of these interactions, which have import for the development of a vaccine against leishmaniasis. In this paper, what is currently understood concerning the mechanisms of leishmanial pathogenesis (based upon studies employing the murine model) is briefly summarized.


Asunto(s)
Leishmania/patogenicidad , Leishmaniasis/etiología , Animales , Modelos Animales de Enfermedad , Inmunidad Celular , Leishmania/clasificación , Leishmania/genética , Leishmaniasis/inmunología , Leishmaniasis Cutánea/inmunología
11.
Mol Immunol ; 47(4): 840-8, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19879650

RESUMEN

DC-SIGN (dendritic cell-specific ICAM-3-grabbing non-integrin) is a myeloid pathogen-attachment factor C-type lectin which recognizes mannose- and fucose-containing oligosaccharide ligands on clinically relevant pathogens. Intracellular signaling initiated upon ligand engagement of DC-SIGN interferes with TLR-initiated signals, and modulates the T cell activating and polarizing ability of antigen-presenting cells. The C-terminal carbohydrate-recognition domain (CRD) of DC-SIGN is preceded by a neck domain composed of eight 23-residue repeats which mediate molecule multimerization, and whose polymorphism correlates with altered susceptibility to SARS and HIV infection. Naturally occurring isoforms and chimaeric molecules, in combination with established recognition properties, were used to define seven structural and functional epitopes on DC-SIGN. Three epitopes mapped to the CRD, one of which is multimerization-dependent and only exposed on DC-SIGN monomers. Epitopes within the neck domain were conformation-independent and unaltered upon molecule multimerization, but were differentially affected by neck domain truncations. Although neck-specific antibodies exhibited lower function-blocking ability, they were more efficient at inducing molecule internalization. Moreover, crosslinking of the different epitopes resulted in distinct levels of microclustering on the cell surface. The identification of independent epitopes on the DC-SIGN molecule might facilitate the design of reagents that modulate the T cell activating and polarizing ability of DC-SIGN-expressing cells without preventing its antigen- and pathogen-recognition capacities.


Asunto(s)
Moléculas de Adhesión Celular/química , Moléculas de Adhesión Celular/inmunología , Mapeo Epitopo , Lectinas Tipo C/química , Lectinas Tipo C/inmunología , Receptores de Superficie Celular/química , Receptores de Superficie Celular/inmunología , Anticuerpos Bloqueadores/inmunología , Anticuerpos Monoclonales/inmunología , Especificidad de Anticuerpos/inmunología , Línea Celular , Células Dendríticas/citología , Células Dendríticas/inmunología , Endocitosis/inmunología , Técnica del Anticuerpo Fluorescente , Humanos , Monocitos/citología , Estructura Terciaria de Proteína
12.
Bol. malariol. salud ambient ; 54(2): 220-235, dic. 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-740288

RESUMEN

El presente trabajo de investigación tiene como finalidad proponer el manejo adecuado de sustancias peligrosas en los laboratorios del Departamento de Biología de la Facultad de Ciencia y Tecnología de la Universidad de Carabobo, de acuerdo a la norma ambiental vigente. El tipo de investigación que se implementó fue documental y de campo. El tiempo de recolección de datos fue de cuatro meses y las herramientas utilizadas para la recolección de los mismos fueron la entrevista, la aplicación de encuesta y el muestreo; se trabajó con una muestra de 54 estudiantes y un técnico y un profesor para cada laboratorio. Se caracterizaron los efluentes una vez tomadas las muestras y también luego de la aplicación de los tratamientos fisicoquímicos (oxidación química para remover la DBO y la DQO) según el parámetro en estudio. Luego de la recolección de datos y el análisis de los resultados se determinó que los laboratorios no están tomando en cuenta un plan de manejo de las sustancias peligrosas que se deben manipular de acuerdo a lo establecido por la normativa legal vigente (Decreto 2635) y que algunos de los efluentes no cumple con los límites máximos permisibles para las descarga a redes cloacales según el Decreto 883. Finalmente se propone mejorar el plan de manejo de sustancias peligrosas mediante el acondicionamiento del depósito de desechos, la elaboración de hojas de seguridad y etiquetas para todos los reactivos, la señalización adecuada dentro de las instalaciones, la incineración de los desechos almacenados en el deposito destinado para ello y el reúso del formol y etanol.


The aim of this study was to propose ways to ensure the correct handling of hazardous substances in laboratories at the Department of Biology, Faculty of Science and Technology, Carabobo University. Both documentary and field data were collected. The survey was completed in four months and consisted of interviews, questionnaires and sampling. A total of 54 students, and one technician and one professor for each laboratory were surveyed. Samples were taken of all effluents and these were characterized before and after physiochemical treatments were implemented (chemical oxidation to remove BDO and CDO) when applicable. The laboratories surveyed did not follow pre-set procedures for the handling of hazardous substances, which should be manipulated according to the provisions of the current legislation (Decree No. 2635). In addition, the concentrations of some of the effluents were higher than the maximum permitted limits for discharge into the sewage system according to Decree No 883. The handling of hazardous substances could be greatly improved by: refurbishing the waste reservoir, drawing up safety data sheets, labelling chemical substances, the use of adequate signage within the facilities, incinerating waste materials stored in the designated warehouse and the reuse of formaldehyde and ethanol.

13.
Invest. clín ; 55(3): 227-237, sep. 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-780158

RESUMEN

Diversos agentes infecciosos interfieren en la progresión del cáncer. En esta investigación se estudió el efecto de la infección o inmunización con Trypanosoma cruzi (Tc) sobre el desarrollo del melanoma maligno. Se utilizaron 258 ratones machos C57BL/6 divididos en 5 grupos melanoma: melanoma control, melanoma Tc inmunizado, melanoma Tc agudo, melanoma Tc crónico y melanoma Tc infectado; 3 grupos controles: control sano, control Tc agudo, control Tc crónico. 100.000 células de melanoma B16-BL6 fueron inoculados vía intramuscular a los grupos melanoma; 3 ó 20 tripomastigotes/g de peso fueron inoculados vía intraperitoneal a los grupos Tc crónicos o Tc agudos previo a la inoculación del melanoma, respectivamente, el grupo melanoma Tc inmunizado fue inoculado con 30.000 epimastigotes fijados en formol y suspendidos en adyuvante completo de Freund, y el grupo melanoma Tc infectado fue inoculado con células de melanoma obtenidas de ratones melanoma Tc agudo. Se evaluó volumen tumoral, supervivencia, parasitemia e histopatología tumoral. Los grupos melanoma Tc: agudo, crónico y melanoma infectado, respectivamente, mostraron una disminución significativa del desarrollo tumoral y de la supervivencia al ser comparados con los grupos melanoma control e inmunizado. Los estudios histopatológicos mostraron áreas de necrosis asociadas con depósitos de melanina, degeneración citopática tumoral y amastigotes intracelulares contenidos en vacuolas parasitofóricas. En conclusión, Tc inhibe el desarrollo tumoral del melanoma maligno y aumenta la supervivencia de ratones C57BL/6, fenómeno que podría estar relacionado con la capacidad invasiva tumoral del parásito y a la respuesta inmune generada.


Some infectious pathogens have the capacity to affect cancer progression. In the present paper we studied the effect of infection or immunization with Trypanosoma cruzi (Tc) against malignant melanoma development. We worked on 258 C57BL/6 male mice divided in five melanoma groups: control melanoma, melanoma Tc acutely infected, melanoma Tc chronically infected, melanoma Tc immunized and infected melanoma; and three control groups: healthy, Tc acutely infected and Tc chronically infected. 100.000 B16-BL6 melanoma cells were inoculated in the thigh of melanoma groups; 3 or 20 trypomastigotes/g were inoculated intraperitoneally in chronic or acute Tc groups, before the melanoma injection, respectively; melanoma Tc immunized were subcutaneously inoculated with 30.000 formaldehide-fixed epimastigotes diluted in complete Freund´s adjuvant and the infected melanoma group was inoculated with melanoma cells obtained from melanoma Tc acutely infected mice. We evaluated survival, parasitemia, tumor volume and tumor histopathology. Results showed that in mice infected with Tc, the tumor development and survival were significantly lower as compared with control melanoma and melanoma Tc immunized. Histopathologically, the tumor displayed necrosis areas with melanin deposits, cytopathic degeneration and amastigotes in parasitophorous vacuoles. In conclusion, Tc inhibits the development of malignant melanoma, increasing C57BL/6 survival, a phenomena that could be related to the parasite tumoral invasive capacity, its ability to produce melanoma cell lysis and to induce a robust immune response.


Asunto(s)
Animales , Masculino , Ratones , Enfermedad de Chagas/inmunología , Melanoma/inmunología , Melanoma/mortalidad , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/mortalidad , Enfermedad de Chagas/complicaciones , Melanoma/complicaciones , Tasa de Supervivencia , Neoplasias Cutáneas/complicaciones
14.
Antimicrob Agents Chemother ; 51(7): 2313-23, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17452477

RESUMEN

AM3 (Inmunoferon) is an orally effective immunomodulator that influences the regulatory and effector functions of the immune system whose molecular mechanisms of action are mostly unknown. We hypothesized that the polysaccharide moiety of AM3 (IF-S) might affect immune responses by modulating the lectin-dependent pathogen recognition abilities of human dendritic cells. IF-S inhibited binding of viral, fungal, and parasite pathogens by human monocyte-derived dendritic cells in a dose-dependent manner. IF-S specifically impaired the pathogen recognition capabilities of DC-SIGN, as it reduced the attachment of Candida, Aspergillus, and Leishmania to DC-SIGN transfectants. IF-S also inhibited the interaction of DC-SIGN with both its cellular counterreceptor (intercellular adhesion molecule 3) and the human immunodeficiency virus (HIV) type 1 gp120 protein and blocked the DC-SIGN-dependent capture of HIV virions and the HIV trans-infection capability of DC-SIGN transfectants. IF-S promoted DC-SIGN internalization in DCs without affecting mannose receptor expression, and (1)D saturation transfer difference nuclear magnetic resonance demonstrated that IF-S directly interacts with DC-SIGN on the cell surface. Therefore, the polysaccharide moiety of AM3 directly influences pathogen recognition by dendritic cells by interacting with DC-SIGN. Our results indicate that DC-SIGN is the target for an immunomodulator and imply that the adjuvant and immunomodulatory actions of AM3 are mediated, at least in part, by alteration of the DC-SIGN functional activities.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Fosfatos de Calcio/farmacología , Moléculas de Adhesión Celular/metabolismo , Células Dendríticas/efectos de los fármacos , Glicopéptidos/farmacología , Lectinas Tipo C/metabolismo , Receptores de Superficie Celular/metabolismo , Adyuvantes Inmunológicos/química , Animales , Aspergillus fumigatus/efectos de los fármacos , Fosfatos de Calcio/química , Candida albicans/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Fluoresceína-5-Isotiocianato , Técnica del Anticuerpo Fluorescente Indirecta , Colorantes Fluorescentes , Glicopéptidos/química , Proteína gp120 de Envoltorio del VIH/metabolismo , VIH-1/patogenicidad , Humanos , Células K562 , Leishmania/efectos de los fármacos , Leucocitos Mononucleares/citología , Polisacáridos/metabolismo , Unión Proteica
15.
Blood ; 109(12): 5337-45, 2007 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-17339424

RESUMEN

Liver and lymph node sinusoidal endothelial cell C-type lectin (LSECtin [CLEC4G]) is a C-type lectin encoded within the liver/lymph node-specific intercellular adhesion molecule-3-grabbing nonintegrin (L-SIGN)/dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)/CD23 gene cluster. LSECtin expression has been previously described as restricted to sinusoidal endothelial cells of the liver and lymph node. We now report LSECtin expression in human peripheral blood and thymic dendritic cells isolated ex vivo. LSECtin is also detected in monocyte-derived macrophages and dendritic cells at the RNA and protein level. In vitro, interleukin-4 (IL-4) induces the expression of 3 LSECtin alternatively spliced isoforms, including a potentially soluble form (Delta 2 isoform) and a shorter version of the prototypic molecule (Delta3/4 isoform). LSECtin functions as a pathogen receptor, because its expression confers Ebola virus-binding capacity to leukemic cells. Sugar-binding studies indicate that LSECtin specifically recognizes N-acetyl-glucosamine, whereas no LSECtin binding to Mannan- or N-acetyl-galactosamine-containing matrices are observed. Antibody or ligand-mediated engagement triggers a rapid internalization of LSECtin,which is dependent on tyrosine and diglutamic-containing motifs within the cytoplasmic tail. Therefore, LSECtin is a pathogen-associated molecular pattern receptor in human myeloid cells. In addition, our results suggest that LSECtin participates in antigen uptake and internalization, and might be a suitable target molecule in vaccination strategies.


Asunto(s)
Antígenos/inmunología , Lectinas Tipo C/inmunología , Células Mieloides/inmunología , Patógenos Transmitidos por la Sangre , Células Dendríticas/inmunología , Endocitosis , Humanos , Lectinas Tipo C/análisis , Lectinas Tipo C/genética , Macrófagos/inmunología , Isoformas de Proteínas , ARN Mensajero/análisis
16.
J Immunol ; 176(10): 6172-9, 2006 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-16670326

RESUMEN

Dendritic cells (DC) play an important role in innate and adaptive immunity, interacting with T cells, NK, and NKT cells. A critical step in the interaction of the parasitic protozoa Leishmania with their host is the evasion of both innate and adaptive immunity, producing a long-lasting chronic infection. There is growing evidence that these parasites can modify the Ag-presenting and immunoregulatory functions of DCs. The cells and mechanisms involved in innate immune response against Leishmania are still poorly understood. In this study, we investigated how Leishmania infantum infection affects DC interactions with NK and invariant NKT (iNKTs) cells in humans. We found that infected immature DCs (iDCs) do not up-regulate HLA class I molecules. Despite this, iDCs become resistant to killing mediated by autologous NK cells due to the up-regulation of HLA-E expression, which protects target cells from NK-mediated lysis through interaction with the inhibitory receptor CD94/NKG2A. Furthermore, iDCs infected with L. infantum up-regulate CD1d cell surface expression and consequently can be efficiently recognized and killed by iNKT cells that produce IFN-gamma. These data suggest that L. infantum could be able to evade NK recognition; in contrast, iNKTs may play an important role in the immune response against Leishmania.


Asunto(s)
Presentación de Antígeno/inmunología , Diferenciación Celular/inmunología , Citotoxicidad Inmunológica , Células Dendríticas/inmunología , Células Dendríticas/parasitología , Células Asesinas Naturales/inmunología , Leishmania infantum/inmunología , Linfocitos T/inmunología , Animales , Células Cultivadas , Células Dendríticas/citología , Células Dendríticas/metabolismo , Humanos , Inmunidad Innata , Células Asesinas Naturales/metabolismo , Linfocitos T/metabolismo
17.
Acta Ophthalmol Scand ; 84(3): 309-13, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16704689

RESUMEN

PURPOSE: Cytokines and other growth factors such as interleukins play an important role in the pathogenesis of proliferative vitreoretinopathy (PVR). Interindividual variations in cytokine production seem to correlate with some cytokine gene polymorphisms. The purpose of this study was to analyse the distribution of these cytokine gene variants in patients with rhegmatogenous retinal detachment (RD) with and without PVR. METHODS: Single nucleotide polymorphisms were analysed for five cytokines: tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta1 (TGF-beta1), interferon-gamma (IFN-gamma), interleukin-6 (IL-6) and interleukin-10 (IL-10). Patients were divided into two surgically treated groups of RD patients: group RD had 27 patients with RD, and group PVR had 31 patients with RD complicated by PVR. A control group was composed of 46 ethnically matched healthy individuals. RESULTS: The genotype distribution of the TGF-beta1 codon 10 polymorphism differed between PVR and RD patients (p = 0.018) and between PVR patients and controls in codon 25 (p = 0.011). There was a higher frequency of TGF-beta1 codon 10 allele T in PVR patients compared with RD patients (p = 0.023). No statistically significant differences between groups were observed for the other polymorphisms examined. CONCLUSION: An association between the TGF-beta1 genetic profile and the development of PVR was detected in this study. Further studies are necessary to confirm this finding and to establish its clinical relevance.


Asunto(s)
Citocinas/genética , Marcadores Genéticos , Predisposición Genética a la Enfermedad/genética , Polimorfismo de Nucleótido Simple , Desprendimiento de Retina/genética , Vitreorretinopatía Proliferativa/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , ADN/genética , Femenino , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Desprendimiento de Retina/complicaciones , Factores de Riesgo , Vitreorretinopatía Proliferativa/complicaciones
18.
Bol. malariol. salud ambient ; 50(2): 187-196, dic. 2010.
Artículo en Español | LILACS | ID: lil-630436

RESUMEN

La presente revisión tuvo como propósito analizar las estrategias para el control de la contaminación debida a la formación de la corrosión e incrustaciones, basado en los factores que afectan el deterioro de los sistemas de distribución de agua potable, así como, su influencia sobre la calidad del agua suministrada al consumidor. Los sistemas de distribución pueden afectar la calidad del agua potable debido a las condiciones de la tubería y a la operación del sistema. La corrosión, las incrustaciones y los depósitos en la red de distribución, son otros de los problemas con mayor importancia en la industria del agua potable; esto puede afectar a la salud, la aceptación pública del suministro de agua y el costo de proveer un agua digna de confianza. Se concluye y se recomienda que como estrategias para controlar la corrosión y la formación de incrustaciones se deben seleccionar apropiadamente los materiales y el diseño del sistema, realizar el tratamiento químico adecuado (ajuste de pH, alcalinidad, oxigeno, uso de inhibidores de corrosión) y usar revestimientos y pinturas resistentes a la corrosión para proteger las paredes de las tuberías.


The aim of this review was to analyze control strategies of contamination caused by the formation of corrosion and incrustations based on factors affecting deterioration of distribution systems of potable water as well as its influence on the quality of water supplied to the consumer. Distribution systems can affect the quality of drinking water due to the conditions of the pipes and the system’s operation. Corrosion, incrustations, and deposits in the distribution network major problems in the drinking water industry. These may affect health, public acceptance of the water supply and the cost of supplying reliable water. We conclude and recommend that, in order to control corrosion and the formation of incrustations, one must select appropriate materials and a sound system design, apply proper chemical treatment (adjusting pH, alkalinity, oxygen, the use of corrosion inhibitors) and use coatings and paints resistant to corrosion in order to protect the walls of the pipes.


Asunto(s)
Humanos , Contaminación del Agua/prevención & control , Calidad del Agua , Control de la Calidad del Agua , Purificación del Agua , Agua Potable , Salud Pública , Purificación del Agua , Abastecimiento de Agua
19.
J Immunol ; 172(2): 1186-90, 2004 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-14707095

RESUMEN

Infection of dendritic cells by the human protozoal parasite Leishmania is part of its survival strategy. The dendritic cell receptors for Leishmania have not been established and might differ in their interactions among Leishmania species and infective stages. We present evidence that the surface C-type lectin DC-SIGN (CD 209) is a receptor for promastigote and amastigote infective stages from both visceral (Leishmania infantum) and New World cutaneous (Leishmania pifanoi) Leishmania species, but not for Leishmania major metacyclic promastigotes, an Old World species causing cutaneous leishmaniasis. Leishmania binding to DC-SIGN was found to be independent of lipophosphoglycan, the major glycoconjugate of the promastigote plasma membrane. Our findings emphasize the relevance of DC-SIGN in Leishmania-dendritic cell interactions, an essential link between innate and Leishmania-specific adaptive immune responses, and suggest that DC-SIGN might be a therapeutic target for both visceral and cutaneous leishmaniasis


Asunto(s)
Moléculas de Adhesión Celular/fisiología , Células Dendríticas/inmunología , Células Dendríticas/parasitología , Lectinas Tipo C/fisiología , Leishmania infantum/crecimiento & desarrollo , Leishmania infantum/inmunología , Leishmania major , Receptores de Superficie Celular/fisiología , Animales , Sitios de Unión/inmunología , Adhesión Celular/inmunología , Moléculas de Adhesión Celular/metabolismo , Células Dendríticas/metabolismo , Glicoesfingolípidos/fisiología , Humanos , Células K562 , Lectinas Tipo C/metabolismo , Leishmania infantum/metabolismo , Leishmania major/crecimiento & desarrollo , Leishmania major/inmunología , Leishmania major/metabolismo , Leishmaniasis Cutánea/inmunología , Leishmaniasis Cutánea/parasitología , Leishmaniasis Visceral/inmunología , Leishmaniasis Visceral/parasitología , Proteínas Opsoninas/metabolismo , Receptores de Superficie Celular/metabolismo , Receptores Inmunológicos/metabolismo , Especificidad de la Especie
20.
Infect Immun ; 71(6): 3172-82, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12761096

RESUMEN

Previous studies have demonstrated that protection against New World leishmaniasis caused by Leishmania amazonensis can be elicited by immunization with the developmentally regulated Leishmania amastigote antigen, P-8. In this study, several independent experimental approaches were employed to investigate the protective immunological mechanisms involved. T-cell subset depletion experiments clearly indicate that elicitation of CD8(+) (as well as CD4(+)) effector responses is required for protection. Further, mice lacking beta(2)-microglobulin (and hence deficient in major histocompatibility complex class I antigen presentation) were not able to control a challenge infection after vaccination, indicating an essential protective role for CD8(+) T effector responses. Analysis of the events ongoing at the cutaneous site of infection indicated a changing cellular dynamic involved in protection. Early postinfection in protectively vaccinated mice, a predominance of CD8(+) T cells, secreting gamma interferon (IFN-gamma) and expressing perforin, was observed at the site of infection; subsequently, activated CD4(+) T cells producing IFN-gamma were primarily found. As protection correlated with the ratio of total IFN-gamma-producing cells (CD4(+) and CD8(+) T cells) to macrophages found at the site of infection, a role for IFN-gamma was evident; in addition, vaccination of IFN-gamma-deficient mice failed to provide protection. To further assess the effector mechanisms that mediate protection, mice deficient in perforin synthesis were examined. Perforin-deficient mice vaccinated with the P-8 antigen were unable to control infection. Thus, the elicitation of CD8(+) T cell effector mechanisms (perforin, IFN-gamma) are clearly required in the protective immune response against L. amazonensis infection in vaccinated mice.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Interferón gamma/fisiología , Leishmania mexicana/inmunología , Leishmaniasis Cutánea/prevención & control , Glicoproteínas de Membrana/inmunología , Glicoproteínas de Membrana/fisiología , Proteínas Protozoarias/inmunología , Vacunas Antiprotozoos/inmunología , Animales , Linfocitos T CD4-Positivos/inmunología , Femenino , Ganglios Linfáticos/inmunología , Ratones , Ratones Endogámicos C57BL , Perforina , Proteínas Citotóxicas Formadoras de Poros , Vacunación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA